Home
Search
Study Topics
Glossary
|
Study 5 of 17 for search of: | "Agammaglobulinemia" |
Previous Study | Return to Search Results | Next Study |
|
|
|
|
|
Sponsored by: |
CSL Behring |
---|---|
Information provided by: | CSL Behring |
ClinicalTrials.gov Identifier: | NCT00322556 |
The objectives of this trial are the assessment of safety and efficacy of IgPro10 in patients with PID, and the assessment of tolerability of high infusion rates. To demonstrate safety, the number of infusions temporally associated with AEs, the rate, severity and relationship of all AEs and the vital sign changes during each infusion will be evaluated.
Condition | Intervention | Phase |
---|---|---|
Agammaglobulinemia IgG Deficiency Common Variable Immunodeficiency |
Drug: Immunoglobulins Intravenous (Human) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Multicenter Extension Study on the Safety and Efficacy of IgPro10 in Patients With Primary Immunodeficiency (PID) |
Estimated Enrollment: | 35 |
Study Start Date: | November 2005 |
Study Completion Date: | April 2008 |
Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 4 Years to 71 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Key Inclusion Criteria:
Key Exclusion Criteria:
Responsible Party: | CSL Behring ( Christian Peters, MD, PhD ) |
Study ID Numbers: | ZLB05_006CR |
Study First Received: | May 5, 2006 |
Last Updated: | September 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00322556 |
Health Authority: | United States: Food and Drug Administration |
Immunoglobulin Intravenous Agammaglobulinemia Hypogammaglobulinemia |
Common variable immunodeficiency Immunoglobulin G Children |
Agammaglobulinemia Common variable immunodeficiency Blood Protein Disorders Hematologic Diseases Immunologic Deficiency Syndromes Lymphatic Diseases Antibodies |
Immunoglobulins, Intravenous Immunoglobulin G IgG Deficiency Rho(D) Immune Globulin Lymphoproliferative Disorders Common Variable Immunodeficiency Immunoglobulins |
Immunologic Factors Immune System Diseases Physiological Effects of Drugs Dysgammaglobulinemia Pharmacologic Actions |